SPPI
(NASDAQ)
2.32
-0.0726  (-3.14%)
Volume (24h): 447.27K Day Range: 2.22 - 2.41
Market Cap: 265.76M 52W Range: 1.74 - 11.36
Mar-28-20 03:30PM Spectrum Pharma (SPPI) Down 4.6% Since Last Earnings Report: Can It Rebound?Zacks
Mar-19-20 03:05AM Edited Transcript of SPPI earnings conference call or presentation 27-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Mar-18-20 10:04PM Edited Transcript of SPPI earnings conference call or presentation 27-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Mar-17-20 11:00AM Spectrum Pharmaceuticals Cancelled Participation in Upcoming Medical Conference Due to Coronavirus PandemicBusiness Wire
04:06AM Edited Transcript of SPPI earnings conference call or presentation 27-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Mar-16-20 10:37PM Edited Transcript of SPPI earnings conference call or presentation 27-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Mar-11-20 11:00AM Spectrum Pharmaceuticals to Present Data from Phase 2 Clinical Trial for Poziotinib at Upcoming Medical ConferenceBusiness Wire
Mar-03-20 12:00PM Spectrum Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2020Business Wire
Mar-02-20 01:00PM The Rosen Law Firm P.A. and Bronstein Gewirtz & Grossman, LLC Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Spectrum Pharmaceuticals, Inc. -- SPPIGlobeNewswire
Feb-28-20 01:46PM Spectrum Pharma (SPPI) Incurs Wider-Than-Expected Q4 LossZacks
Feb-27-20 09:00PM Spectrum Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Pipeline UpdateBusiness Wire
Feb-20-20 02:27PM What Awaits Spectrum Pharmaceuticals (SPPI) in Q4 Earnings?Zacks
12:00PM Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results Conference CallBusiness Wire
Feb-06-20 12:00PM Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum Oncology Day on February 13thBusiness Wire
Jan-17-20 10:50PM Spectrum Pharmaceuticals (SPPI) Stock Sinks As Market Gains: What You Should KnowZacks
Jan-15-20 06:39PM Such Is Life: How Spectrum Pharmaceuticals (NASDAQ:SPPI) Shareholders Saw Their Shares Drop 68%Simply Wall St.
Dec-27-19 07:50PM Spectrum Pharma Analyst Says Sell-Off May Have Been OverdoneBenzinga
01:05PM Spectrum Pharmaceuticals is Oversold: Can It Recover?Zacks
Dec-27-19 12:59PM The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes ShoppingBenzinga
11:56AM Spectrum Pharmaceuticals shares slide 57% after lung cancer trial misses goalsMarketWatch
Dec-26-19 08:57PM PreMarket Prep Recap: Qiagen Pulls The Rug Out From Investors Banking On A Deal, Bad Data Equals Bad Price Action For Spectrum PharmaceuticalsBenzinga
06:37PM Spectrum Pharmaceuticals shares slide 57% after lung cancer trial misses goalsMarketWatch
Dec-26-19 03:31PM Stocks post gains in thin post-Christmas tradeMarketWatch
01:33PM UPDATE: Spectrum Pharma shares slide 47% premarket after trial of lung cancer treatment misses main goalMarketWatch
Dec-26-19 12:55PM The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer SharesBenzinga
12:20PM Spectrum Pharma shares slide 17% premarket after trial of lung cancer treatment misses main goalMarketWatch
Dec-26-19 12:00PM Spectrum Pharmaceuticals Provides Pipeline Update on Late Stage ProgramsBusiness Wire
10:57AM Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II EndpointTheStreet.com
Dec-17-19 03:01PM Hedge Funds Are Dumping Spectrum Pharmaceuticals, Inc. (SPPI)Insider Monkey
Dec-07-19 04:31PM Why Is Spectrum Pharma (SPPI) Up 23.9% Since Last Earnings Report?Zacks
Dec-05-19 11:32AM Will Spectrum Pharmaceuticals Continue to Surge Higher?Zacks
Nov-27-19 01:44PM Options Traders Expect Huge Moves in Spectrum Pharmaceuticals (SPPI) StockZacks
Nov-17-19 02:40AM Edited Transcript of SPPI earnings conference call or presentation 7-Nov-19 9:30pm GMTThomson Reuters StreetEvents
Nov-16-19 11:28PM Edited Transcript of SPPI earnings conference call or presentation 7-Nov-19 9:30pm GMTThomson Reuters StreetEvents
Nov-15-19 07:48AM Edited Transcript of SPPI earnings conference call or presentation 7-Nov-19 9:30pm GMTThomson Reuters StreetEvents
Nov-14-19 02:57PM Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 London Healthcare Conference on November 21stBusiness Wire
12:00PM Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 London Healthcare Conference on November 21stBusiness Wire
Nov-09-19 12:11AM Edited Transcript of SPPI earnings conference call or presentation 7-Nov-19 9:30pm GMTThomson Reuters StreetEvents
Nov-08-19 03:08PM Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on RolontisZacks
Nov-07-19 09:00PM Spectrum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Pipeline UpdateBusiness Wire
Oct-31-19 11:00AM Spectrum Pharmaceuticals Announces Third Quarter 2019 Financial Results Conference CallBusiness Wire
Oct-28-19 08:21PM Here’s What Hedge Funds Think About Spectrum Pharmaceuticals, Inc. (SPPI)Insider Monkey
Oct-24-19 08:00PM Spectrum Pharmaceuticals Announces Submission to the U.S. Food and Drug Administration of Updated Biologics License Application for ROLONTIS®Business Wire
Oct-23-19 03:16PM Is the Options Market Predicting a Spike in Spectrum Pharma (SPPI) Stock?Zacks
Oct-04-19 11:00AM Spectrum Pharmaceuticals Announces Publication of Positive Poziotinib Data in Cancer CellBusiness Wire
Oct-01-19 06:58PM We're Hopeful That Spectrum Pharmaceuticals (NASDAQ:SPPI) Will Use Its Cash WiselySimply Wall St.
Sep-27-19 03:03PM FibroGen Begins Study on Roxadustat for Chemo-Induced AnemiaZacks
Sep-25-19 11:00AM Spectrum Pharmaceuticals to Present Corporate Update at the 2019 Cantor Global Healthcare Conference on October 2ndBusiness Wire
Sep-20-19 03:54PM FibroGen's Evrenzo Gets Nod in Japan for Anemia with CKDZacks
Sep-09-19 03:14PM Will These 2 Falling Knives Bounce Back?GuruFocus.com
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for peripheral T-cell lymphoma (PTCL); ZEVALIN injection for patients with B-cell non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB for treating breast and lung cancer; ROLONTIS for chemotherapy-induced neutropenia; and QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer. The company sells its drugs through group purchasing organizations, wholesalers, and directly in the United States; and through distributors in Europe. Spectrum Pharmaceuticals, Inc. has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)